RNPC3 and systemic sclerosis: Anti-U3 RNP antibodies have been detected in 5–8 % of patients with systemic sclerosis, and antibody-positive patients with systemic sclerosis have shown more frequent skeletal muscle involvement than that of antibody-negative patients with systemic sclerosis.